Background {#Sec1}
==========

Global left ventricular (LV) remodeling after myocardial infarction frequently occurs. Late Gadolinium Enhancement (LGE) CMR allows imaging of focal myocardial scar with areas remote from scar having no hyperenhancement. Myocardial T~1~ mapping allows quantification of interstitial fibrosis and may be a surrogate for LV remodeling. We sought to determine if there were T~1~ abnormalities in remote regions (no LGE positive areas) in patients with prior myocardial infarction.

Methods {#Sec2}
=======

In a prospective IRB-approved study, 12 patients with a history of coronary artery disease (CAD) and chronic myocardial infarction (61 ± 9 years, 9 males) and 10 healthy subjects (52 ± 10 years, 8 males) were recruited to undergo CMR scans. All subjects were in sinus rhythm during CMR study. We assessed native T~1~ mapping using the slice interleaved T~1~ sequence in 5 short axis-slices (from apical to basal). The sequence was acquired in a free-breathing ECG-triggered slice-selective bSSFP. T~1~ mapping of each scan was estimated by voxel-wise curve fitting using a 2-paramter fit model. All images were corrected for in-plane motion between different T~1~ weighted scans. Native myocardial T~1~ in healthy subjects were measured over the three mid-ventricular slices by manually drawing epicardial and endocardial contours. The native T~1~ times of the remote myocardium of the CAD patients were measured by manually drawing a region of interest (ROI) on the three mid-ventricular slices and excluding the infarct area. An unpaired-samples T-test analysis was used to test for statistically significant differences between the two groups.

Results {#Sec3}
=======

Patient characteristics are summarized in Table [1](#Tab1){ref-type="table"}. LGE hyperenhancement was observed in all CAD patients. The mean native T~1~ time in the remote area myocardium of the CAD patients was significantly *higher* than the native T~1~ value of the myocardium in the healthy group (1107 ± 36 ms. vs. 1061 ± 32 ms.; p = 0.005) (Figure [1](#Fig1){ref-type="fig"}).Table 1Subject characteristics of CAD patients and healthy cohorts with p-values of comparison.CAD Patients (N = 12)Healthy Cohorts (N = 10)Comparison (p-value)Male, %75% (N = 9)80% (N = 8)Age, years61 ± 952 ± 100.029Height, cm174 ± 8174 ± 80.936Weight, kg82 ± 1881 ± 170.893Hypertension, %75% (N = 9)Type 2 Diabetes, %25% (N = 4)BSA, m21.99 ± 0.241.98 ± 0.250.918SBP, mmHg115 ± 16112 ± 140.63DBP, mmHg64 ± 1261 ± 110.633HR, beats per minute64 ± 1158 ± 90.188EDV-Cine, ml231 ± 61175 ± 270.011ESV-Cine, ml146 ± 5273 ± 190.0001SV-Cine, ml84 ± 24102 ± 9.50.033EF-Cine, %37 ± 959 ± 50.0001LV-mass, grams128 ± 32102 ± 140.022Figure 1**boxplot with mean (line in box), interquartile range (box) and complete range (whisker) of native T1 time in remote myocardium of CAD patients and healthy cohorts (p = 0.0005)**.

Conclusions {#Sec4}
===========

Our data suggest there are diffuse changes in remote/normal myocardium resulting in abnormal/higher native T~1~ times in CAD patients with prior myocardial infarction. Further studies are needed to assess the prognostic value of an abnormal native T~1~ in the remote region among CAD patients.
